KBWB Stock UPDATES KBW Bank Powershares (KBWB) 35.38 10/23/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
KBW Bank Powershares (KBWB) 35.38 $KBWB

Q3 Bank Earnings Put These Financial ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 10:26AM CDT
These financial ETFs are under the microscope following a slew of bank earnings reports.
GS: 180.06 (+3.23), KBWB: 35.38 (+0.30), JPM: 58.06 (+0.61), IAI: 38.60 (+0.62), C: 51.41 (+0.71), WFC: 50.60 (+0.43), XLF: 22.88 (+0.22), IYG: 83.86 (+0.93)

Will Cyber Attack Halt Rally in Financial ETFs? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Sep 04, 12:00PM CDT
A series of cyber attacks last week hit number of U.S. banks. Will it be a major drag on the financial ETFs in the coming months?
KBWB: 35.38 (+0.30), JPM: 58.06 (+0.61), RKH: 54.43 (+0.45), IYG: 83.86 (+0.93)

Banking Earnings Beats Fail to Boost Financial ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Jul 22, 11:02AM CDT
Strong earnings have not been enough to boost these financial ETFs, but a surge may just be around the corner.
KBWB: 35.38 (+0.30), JPM: 58.06 (+0.61), RKH: 54.43 (+0.45), IAI: 38.60 (+0.62), C: 51.41 (+0.71), BAC: 16.60 (+0.20), IYG: 83.86 (+0.93)

Is Citigroup Plan Rejection Trouble for These ETFs? - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Mar 28, 1:00PM CDT
Investors should watch these ETFs for further weakness in the days ahead and take advantage of the lower price resulting from Citigroup.
KBWB: 35.38 (+0.30), RWW: 46.76 (+0.24), C: 51.41 (+0.71), IYG: 83.86 (+0.93)

Bank on Dividends with These Financial ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 1:00PM CST
Looking for dividends? Try these financial ETFs for exposure.
KBWB: 35.38 (+0.30), C: 51.41 (+0.71), BAC: 16.60 (+0.20), XLF: 22.88 (+0.22), IYG: 83.86 (+0.93), MS: 33.96 (+0.53)

Top Ranked Financial ETF in Focus: KBWB - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Sep 18, 9:01AM CDT
Time to take a closer look at this top ranked financial ETF?
KBWB: 35.38 (+0.30), XLF: 22.88 (+0.22)

Zacks Investment Ideas feature highlights: SPDR Select Sector Financial Fund, consumer discretionary, iShares U.S. Insurance ETF, PowerShares KBW Bank Portfolio and iShares US Broker Dealers ETF
PR Newswire - Wed Jul 31, 8:30AM CDT
Today, Zacks Investment Ideas feature highlights Features: SPDR Select Sector Financial Fund (AMEX:XLF-Free Report), consumer discretionary (AMEX:XLY-Free Report), iShares U.S. Insurance ETF (AMEX:IAK-Free Report), PowerShares KBW Bank Portfolio (AMEX:KBWB-Free Report) and iShares US Broker Dealers ETF (AMEX:IAI-Free Report).
KBWB: 35.38 (+0.30), IAK: 46.48 (-0.14)

The Best ETFs in the Market's Top Sector - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Tue Jul 30, 8:52AM CDT
Financials have been all-stars this year, but which ETFs have been leading the way higher in the space?
KBWB: 35.38 (+0.30), IAK: 46.48 (-0.14), IAI: 38.60 (+0.62), XLF: 22.88 (+0.22)

Is Trouble on the Horizon for Big Bank ETFs? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jun 19, 11:45AM CDT
Should investors be worried about elevated rates impacting big bank ETFs?
KBWB: 35.38 (+0.30), JPM: 58.06 (+0.61), RKH: 54.43 (+0.45), C: 51.41 (+0.71), IYG: 83.86 (+0.93)

Banking ETFs: Laggards or Leaders? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Mar 27, 7:45AM CDT
Should investors be buying bank ETFs at this time?
KBE: 31.23 (+0.18), KBWB: 35.38 (+0.30), JPM: 58.06 (+0.61), C: 51.41 (+0.71), XLF: 22.88 (+0.22)

What's Driving Bank ETFs Higher? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Feb 20, 12:59PM CST
Better-than-expected earnings have resulted in strong performance by the Bank ETFs.
KBE: 31.23 (+0.18), KBWB: 35.38 (+0.30)

Financial ETFs Set to Rally in Earnings Season - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Jan 18, 1:17PM CST
Should investors look to these financial ETFs for strong performances this earnings season?
KBE: 31.23 (+0.18), KBWB: 35.38 (+0.30), XLF: 22.88 (+0.22)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

OUTFRONT Media Gears Up for Q3 2026 Earnings Reveal

Updated Category News Views 3

OUTFRONT Media’s Earnings Drumroll Heading toward that red-letter date of November 5, OUTFRONT Media (NYSE: OUT) has got its ducks in a row. They're ready to spill the beans on third-quarter numbers after close of market—just as clocks hit 4:30 p.m. Eastern. It’s showtime, folks. What’s at Stake? We're talking OUTFRONT Media—one of the big kahunas in out-of-home...

Continue Reading
WF Holding Cancels Additional Purchase Rights in Deal

Updated Category News Views 4

WF Holding Calls Off Extra Purchase Rights Well, someone's decided to hit the brakes over at WF Holding Limited (NASDAQ:WFF). They're pulling the plug on an extra purchase gravy train they’d previously left open for investors. Straight from Kuala Lumpur, WF Holding's been in the fiberglass plastic game for over three decades, pushing out a product line that's almost as...

Continue Reading
Pediatric Dental Visits: Setting the Stage Early Matters

Updated Category News Views 4

Unlocking the Secrets of First Dental Visits When should little ones start showing up in that dental chair? You might be thinking, "I'll wait until they actually have a full set of chompers," but that's a rookie move, folks. A piece coming out of HelloNation suggests parents hustle those kiddos into the dentist's office by their first birthday or six months after the...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 3

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
Guwahati Training Elevates Ophthalmologists: More Ready Surgeons

Updated Category News Views 4

Expanding Horizons: Training Where It's Needed The universe of cataract surgery in India saw an encouraging turn with HelpMeSee's recent initiative in Guwahati. This operation hit the sweet spot for Northeast India's ophthalmologists by bringing top-notch surgical training directly to their doorstep. Bye-bye long, costly trips to distant cities for training—this time,...

Continue Reading
3D Concrete Printing Set to Transform Construction by 2035

Updated Category News Views 3

Concrete Revolution: The 3D Printing Surge Times are changing in construction, and this ain’t your grandfather’s cinder block. We're talking about 3D concrete printing here—an industry poised to swell from just a pipedream sort of $293.4 million in 2025 to a staggering $1.87 billion by 2035. Driven by housing demands and resilient defense contracts, the sector is...

Continue Reading
Direct Digital's Bold Exit: Delists from Nasdaq

Updated Category News Views 3

Delisting Drama: Navigating Direct Digital's Market Move Looks like Direct Digital Holdings is getting caught up in the whirlwind of delisting and deregistering its Class A common stock from the Nasdaq. This move isn't just about hopping off a big exchange—it’s a whole new set of dance steps in the market. Timing and Mechanics of the Departure They’ve set their...

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 0

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
FFR Set to Unveil Strategy at Nasdaq Event in NYC

Updated Category News Views 12

An Exciting Day for FFR on Wall Street Hold onto your hats, investors! FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is about to make a splash in the big leagues at its much-anticipated Nasdaq listing ceremony. Slated for October 26 at the iconic Nasdaq Tower in NYC, it's a day that could pivot the company’s future centerpiece strategy, jacking up anticipation like...

Continue Reading
Factors Driving Up Car Window Tinting Costs Explained

Updated Category News Views 2

Decoding the Dollars Behind Car Window Tinting When you think about car upgrades, window tinting might not scream excitement. But, my friends, it ain't all about the aesthetics. Dive into the nuts and bolts of cost with insights from Francis Alegre, a seasoned pro from StayShine Detailing in Voorhees, New Jersey, featured in HelloNation's rundown. The Glass Mass Factor...

Continue Reading

Top 5 Most Recently Viewed Articles

Definitive Healthcare Celebrated as a Top Boston Employer

Updated Category News Views 89

Definitive Healthcare Honored as a Premier Workplace Definitive Healthcare (NASDAQ: DH), a leading name in healthcare commercial intelligence, has recently earned prestigious recognition as one of the top employers in Boston. Celebrated by Built In’s 2025 Best Places to Work program, this accolade acknowledges businesses that foster exceptional workplace environments....

Continue Reading
Euroseas Q4 Earnings Beat Expectations: Key Insights

Updated Category News Views 157

Euroseas Earnings Report: Highlights and Performance The market loves a good surprise, and Euroseas just tossed a nice one into the mix with their latest earnings. Released February 25, 2026, at 08:00 AM, they’ve performed better than expected, snagging attention from investors ready for a ride. Earnings Overview Let’s cut to the chase: Euroseas reported an earnings...

Continue Reading
AstraZeneca and Daiichi Sankyo's Datroway: A Game Changer

Updated Category News Views 208

Introduction to Datroway's Impact on Breast Cancer Treatment AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo have announced remarkable findings from their TROPION-Breast02 Phase 3 trial for the drug Datroway (datopotamab deruxtecan), set to revolutionize the approach to treating triple-negative breast cancer (TNBC). This pharmaceutical collaboration showcases significant...

Continue Reading
Compute Exchange Revolutionizes AI Compute Market Dynamics

Updated Category News Views 806

Compute Exchange Revolutionizes AI Compute Market Dynamics Today marks a significant shift in the way AI compute resources are bought and sold with the introduction of Compute Exchange. This pioneering platform provides the first open exchange specifically designed for GPUs and various other compute resources, addressing the needs of both buyers and sellers in an...

Continue Reading
NuZee Stock Surges on Major Operational Changes and Leadership Shift

Updated Category News Views 88

NuZee Inc. Makes Headlines with Strategic Relocation NuZee, Inc. NUZE is witnessing a significant surge in its stock trading activity. The reason behind this movement is the recent announcement of the company relocating its U.S. operations from California to Florida. This strategic decision aims to bolster its operational efficiency and accessibility. Global Expansion...

Continue Reading